DAVIE, FL / ACCESSWIRE / August 27, 2019 / College students get sick just like anyone else, the issues are, they’re far away from the regular primary care doctor, emergency rooms are packed with people, and the cost is exorbitant, and while urgent care centers are viable options, are there any close by, and what time are they open?

Back to campus means many things, new friends, hard work, good grades and-dun, dun, dun, dun-contagious infections. It’s true; college students are surrounded by bacterial and viral infections on a daily basis.

Viruses & Bacteria

Along with many others, staph infection, MRSA, and impetigo are all communicable forms of viral infections that are easily transmittable. When it comes to bacterial infections, those include sinusitis, food poisoning, meningitis, and upper respiratory infections, to name a few.

Fungal Infections

In addition to viral infections, your student is vulnerable to fungal skin cross-contamination. If they come into contact with dirty towels, clothing, sports equipment, cell phones, or even hard surfaces, some infections pass from one person to the next very quickly. A good example of this is ringworm. Contrary to its name, ringworm is not caused by a parasite, but rather by fungus. It gets its name from the predictable red rings that it produces. It usually appears on the lower part of the body or abdomen, but can occur anywhere, even on the scalp.

When students get sick, it’s usually an inopportune time. When you sign your child up for Protect My College Student, all they have to do is chat with a medical professional via their phone or device and the physician or practitioner will diagnose their condition and take the next steps to get them feeling better. It’s that easy.

Protect My College Student

Utilizing MD Live’s telemedicine services, students can contact doctors and healthcare professionals 24/7 via their phone, laptop, or iPad. Protect My College Student’s goal is to provide parents peace of mind as their children go off to college and are living away from home for the first time. This can be an uneasy time for parents, but knowing that their students have unlimited access to medical services and counseling is reassuring.

The advantage of telemedicine is that you can access reliable healthcare from your phone, tablet, or computer at any time. Protect My College Student’s network of experienced healthcare professionals are ready to assist with a variety of needs including urgent care visits; colds, stomach issues, fever, flu, earaches, pink eye, migraines, nausea and more.

While a large number of colleges offer medical services, they may be limited on availability. Protect My College Student offers students immediate assistance, 24/7, and can also assist them if they are traveling. Students can access these services with any mobile device or computer with Wi-Fi access. Medical professionals can diagnose a condition, advise patients where to go for further assistance, recommend over-the-counter medications, or prescribe medications from a local pharmacy, all during the consultation.

Protect My College Student offers around the clock care and protection for students who are living away from home for the first time.

Protect My College Student
13762 W State Rd. 84,
Suite 53
Davie, FL 33325
800-767-7746

SOURCE: Web Presence

ReleaseID: 557611

With the Changing Medical Landscape, AISM Ensures that Your Skills and Employability Remain at Their Peak with this New Diploma

ATLANTA, GA / ACCESSWIRE / August 27, 2019 / The American International School of Medicine (AISM) is proud to announce the launch of the new diploma focused on AI in Medicine. This diploma made possible for the “Alumni and the Undergraduate” is another part of AISM’s commitment to educate future physicians to lead innovation in science and medicine. Both the Alumni and Undergraduate are conducted entirely online and have both three month and year long options based upon individual preference.

“The American International School of Medicine is committed to remaining on the cutting edge of medical technology and with the rise of Artificial Intelligence in the industry we felt that it was important for us to start offering courses for it,” says Dr. Colin Wilkinson. “AI is exploding into every aspect of our lives and healthcare will be one of the industries to receive the biggest disruption.”

While this diploma is going to be mainstays at the AISM, there are benefits if you sign up before September 2nd. For the Undergraduate, you will pay no sign-up fees if you pay for the courses before the deadline. For the Alumni there is a special alumni price of just $999, a $300 discount for the three-month diploma and an $800 discount on the year-long diploma.

For more information and to register for the diplomas, please visit: https://aism.edu/undergraduate-ai-diploma/

https://aism.edu/alumni-ai-diploma/

About AISM

The American International School of Medicine began in 1999 and has graduated hundreds of medical doctors who are in specialty clinical and or training and or practicing medicine in the USA, Guyana, UK, Pakistan, Caribbean, and other countries worldwide. We focus in training physicians who can excel in patient-care research and education as a part of their professional development process. The American International School of Medicine has campuses in Atlanta, Guyana, England, and Nigeria. Our students participate in clinical rotations at hospitals in United States, Canada, UK (London), Guyana and Elective rotations in other countries.

Contact:

Nancy Akunna
Phone: +1 470 345 0976
Email: admissions@aism.edu

SOURCE: American International School of Medicine

ReleaseID: 557610

BERKELEY, CA / ACCESSWIRE / August 27, 2019 / Orthodox monetary policies of many nations are powering the rich to be richer and poor to be poorer – that’s a whopping 90% of the world’s population.

“The promise of globalization has failed because ONE critical tool has been missing from day one – a single universal currency to facilitate the exchange of goods and services without breaking the backs of ordinary people with exorbitant foreign exchange fees,” says one of the Milky Way Founders of the Swiss Shakti Stiftung.

Going back to the basics, what was the goal of globalization? To improve the quality of life for those who belong to the marginal communities across the world, whether they live in developed or developing countries. Let’s unpack it with a practical question for the benefit of economic policy advisors and leaders of thoughts; how many Automotive Engineers can change engine oil? Probably, almost everyone can if they want to do it.

They have the intellect, hands-on experience with ongoing professional training, and above all, access to knowledgeable friends just a phone call away. Moreover, automakers design their vehicles for ordinary people to follow do-it-yourself instructions for performing essential maintenance such as changing the engine oil. Almost all car owners can change the oil if they’re willing to, irrespective of them being an automotive engineer.

But almost everyone will fail miserably without the appropriate tool! On the other hand, if they all have access to hydraulic lift or ramp, all of them will be capable of changing the engine oil. Any attempt to get the same job done without the necessary equipment to perform the same task – such as a manual or a hi-lift scissor jack or a portable ramp will break their backs. That’s why 90% of the world’s population lives on hand-to-mouth – paycheque to paycheque because they are all using the wrong tool to exchange their valuables around the globe.

There is no going back to the globalization we once deemed possible. We no longer can work with a relic monetary tool if we wish to see the marginalized families live to their full potential. The global population needs a single currency that’s available to all. The currency should be practical, easy to use, and simple enough for people across the world to understand it, see it, touch it and enjoy the benefits of using it. Moreover, every time that “single” currency gets used, it must aid and add material value in the lives of ordinary human beings – not just for the ultra-rich.

Shakti Coin is one such currency – its protocol is transparent and straightforward. It is smart, practical, and as powerful as the hydraulic lift. Further, it is easily understood by those who need it most. This blockchain-powered cryptocurrency fixes school attendance and extends financial inclusion to the weakest by using a new protocol – Proof-of-Effort (PoE). This will propel every family on the planet Earth to educate their children and reward those who try every day.

Shakti Coin’s four-part whitepaper defines the various social and economic benefits that it offers to communities, with its stable coin ecosystem.

About Shakti Coin:

The Shakti Coin project is an international grassroots initiative that exists independent of any affiliation with industry, government, religion or political party. Learn more at https://www.shakticoin.com.

Media contact:
Swiss Shakti Foundation
secretariat@shakticoin.com

Additional features:
Picture: http://newsfeed2.eqs.com/shakti/863533.html

SOURCE: Swiss Shakti Foundation

ReleaseID: 557603

NEW YORK, NY / ACCESSWIRE / August 27, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Realogy Holdings Corp. (NYSE:RLGY)

Lawsuit on behalf of: investors who purchased February 24, 2017 – May 22, 2019
Lead Plaintiff Deadline : September 9, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/realogy-holdings-corp-loss-form?prid=3208&wire=1

According to the filed complaint, during the class period, Realogy Holdings Corp. made materially false and/or misleading statements and/or failed to disclose that: (1) Realogy was engaged in anticompetitive behavior by requiring property sellers to pay the commissions of a buyer’s broker at an inflated rate; (2) Realogy’s anticompetitive actions would prompt the U.S. Department of Justice (“DOJ”) to open an antitrust investigation into the real estate industry’s practices regarding brokers’ commissions; and (3) as a result, Defendants’ statements about the Realogy’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Omnicell, Inc. (NASDAQ:OMCL)

Lawsuit on behalf of: investors who purchased October 25, 2018 – July 11, 2019
Lead Plaintiff Deadline : September 16, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/omnicell-inc-loss-form?prid=3208&wire=1

According to the filed complaint, during the class period, Omnicell, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company recognized revenue for certain transactions before fulfilling its performance obligations; (2) the Company engaged in improper accounting practices to meet revenue targets; (3) the Company experienced weaker demand for new product lines than it had previously projected; (4) as a result, the Company would be required to write-off certain inventory; (5) the Company misclassified certain expenses as capitalized expenditures; and (6) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Granite Construction Incorporated (NYSE:GVA)

Lawsuit on behalf of: investors who purchased October 26, 2018 – August 1, 2019
Lead Plaintiff Deadline : October 15, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/granite-construction-incorporated-loss-form?prid=3208&wire=1

According to the filed complaint, during the class period, Granite Construction Incorporated made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had assumed certain risks in connection with its heavy civil joint venture projects bid between 2012 and 2014; (2) there was an “untenable” imbalance of risk sharing between the Company and the joint venture project owners; (3) as a result, the Company was reasonably likely to incur additional project costs for its joint venture projects; (4) the Company was reasonably likely to incur additional costs in connection with certain project disputes; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects and prospects were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 557601

CEDARHURST, NY / ACCESSWIRE / August 27, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No classes have yet been certified in the actions below. Appointment as lead plaintiff is not required to partake in any recovery.

Just Energy Group Inc. (NYSE:JE)

Investors Affected: November 9, 2017 – July 23, 2019

A class action has commenced on behalf of certain shareholders in Just Energy Group Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company experienced customer enrollment and nonpayment issues; (2) as a result, the Company was reasonably likely to incur an impairment charge to its accounts receivable; (3) as a result, the Company lacked adequate internal control over its financial reporting; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://kclasslaw.com/securities/just-energy-group-inc-loss-submission-form/?id=3207&from=1.

International Flavors & Fragrances Inc. (NYSE:IFF)

Investors Affected: May 7, 2018 – August 5, 2019

A class action has commenced on behalf of certain shareholders in International Flavors & Fragrances Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) that Frutarom Industries Ltd. (“Frutarom”), which the Company acquired in 2018, had bribed customers in Russia and Ukraine; (2) that senior management at Frutarom were aware of such improper payments; (3) that, as a result, Frutarom’s financial results were materially overstated; (4) that, as a result of the improper payments, the Company was reasonably likely to face regulatory scrutiny; (5) that the Company had not completed adequate due diligence before acquiring Frutarom; (6) that, as a result of the foregoing, the Company was unlikely to achieve purported synergies from the acquisition; and (7) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://kclasslaw.com/securities/international-flavors-fragrances-inc-loss-submission-form/?id=3207&from=1.

Evolent Health, Inc. (NYSE:EVH)

Investors Affected: March 3, 2017 – May 28, 2019

A class action has commenced on behalf of certain shareholders in Evolent Health, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Evolent’s partnership model was not aligned with its partners, as it was designed to parasitically increase its own revenue by extracting enormous administrative and management fees at the expense of its partners such as Passport Health Plan (“Passport”); (2) Passport was struggling financially, particularly after Kentucky cut its reimbursement rates, and the partnership between Evolent and Passport was becoming increasingly unsustainable; (3) Evolent was draining Passport of functions, employees, and money to such an extent that Passport was left on the verge of insolvency; (4) for several months, Passport was conducting a bidding process to sell itself to a financial buyer to prevent liquidation; and (5) as a result of the foregoing, Defendants public statements were materially false and/or misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://kclasslaw.com/securities/evolent-health-inc-loss-submission-form/?id=3207&from=1.

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: dk@kclasslaw.com
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967

SOURCE: Kuznicki Law PLLC

ReleaseID: 557590

NEW YORK, NY / ACCESSWIRE / August 27, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Fred’s, Inc. (NASDAQ:FRED)
Class Period: December 20, 2016 to June 28, 2017
Lead Plaintiff Deadline: August 27, 2019

According to the filed complaint, defendants made numerous materially false and misleading statements concerning the level of regulatory risk faced by the Original Merger and the Revised Merger which would ultimately cause the termination of the Fred’s Asset Purchase Agreement. Specifically, Defendants made false and/or misleading statements: (i) downplaying or disputing contrary reports from journalists signaling regulatory turbulence in closing the merger; (ii) representing that inside knowledge of the FTC gave confidence that the deal would close.

Learn about your recoverable losses in FRED: http://www.kleinstocklaw.com/pslra-1/freds-inc-loss-submission-form?id=3206&from=1

Netflix, Inc. (NASDAQ:NFLX)
Class Period: April 17, 2019 to July 17, 2019
Lead Plaintiff Deadline: September 20, 2019

Throughout the class period, Netflix, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Netflix would not be able to gain its expected target number of new subscribers in the second quarter of 2019; (2) Netflix would also lose subscribers from the United States in the second quarter of 2019; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in NFLX: http://www.kleinstocklaw.com/pslra-1/netflix-inc-loss-submission-form?id=3206&from=1

Cardinal Health, Inc. (NYSE:CAH)
Class Period: March 2, 2015 to May 2, 2018
Lead Plaintiff Deadline: September 30, 2019

The lawsuit alleges Cardinal Health, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: 1) following Cardinal’s acquisition of Cordis, the RFID [radio-frequency identification] inventory tracking technology and advanced supply chain solutions that Defendants told investors the Company would to use to improve Cordis’s performance were never implemented across Cordis; 2) Cordis’s antiquated and ineffective global supply chain was causing operational and inventory problems at Cordis; 3) as a result, Cordis manufactured and accumulated excessive amounts of cardiovascular product inventories, which sat on the shelf and became unsellable and/or expired; 4) the Company materially overstated Cordis’s inventory balances; 5) Cordis was not “performing well” and its integration was not “on track,” “going incredibly well” or “largely on plan”; and 6) to correct Cordis’s deficiencies, the Company would have to make substantial investments in Cordis’s IT and supporting infrastructure, thereby incurring significant Selling, General and Administrative Expenses charges beyond the levels internally budgeted or projected by Cardinal and diminishing operating earnings.

Learn about your recoverable losses in CAH: http://www.kleinstocklaw.com/pslra-1/cardinal-health-inc-loss-submission-form?id=3206&from=1

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 557589

NEW YORK, NY / ACCESSWIRE / August 27, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Intelligent Systems Corporation (NYSE:INS)
Class Period: January 23, 2019 to May 29, 2019
Lead Plaintiff Deadline: September 9, 2019

According to the complaint, Intelligent Systems Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Defendant Petit, the “financial expert” on the Company’s Audit Committee, engaged in accounting fraud as the CEO of MiMedx Group; (2) the Company’s CEO, Defendant Strange, engaged in undisclosed related-party transactions with Defendant Petit and others and had an undisclosed personal relationship with the Company’s auditor; (3) the Company had its employees set up or take control of shell companies in Asia so they could partake in undisclosed related-party transactions for the purpose of either fabricating revenue for the Company and/or siphoning money out of the Company; and (4) as a result, Defendants’ statements about Intelligent Systems’ business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in INS: http://www.kleinstocklaw.com/pslra-1/intelligent-systems-corporation-loss-submission-form?id=3205&from=1

L Brands, Inc. (NYSE:LB)
Class Period: May 31, 2018 to November 19, 2018
Lead Plaintiff Deadline: September 23, 2019

L Brands, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) the Victoria’s Secret and PINK businesses were having a material adverse effect on the Company’s cash flow, liquidity and debt levels; (b) Defendants lacked a reasonable basis for their positive statements about the ability of the Company to sustain its dividend; (c) the MD&A disclosures in filings L Brands made with the SEC were materially false and misleading; (d) the risk factor disclosures in filings L Brands made with the SEC were materially false and misleading; (e) the representations about L Brands’ disclosure controls in filings the Company made with the SEC were materially false and misleading; (f) the certifications issued by Defendants Wexner and Burgdoerfer on L Brands disclosure controls were materially false and misleading; and (g) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about L Brands’ then-current business operations and future financial
prospects.

Learn about your recoverable losses in LB: http://www.kleinstocklaw.com/pslra-1/l-brands-inc-loss-submission-form?id=3205&from=1

GTT Communications, Inc. (NYSE:GTT)
Class Period: February 26, 2018 to July 1, 2019
Lead Plaintiff Deadline: September 30, 2019

The complaint alleges that during the class period GTT Communications, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) following GTT’s acquisition of Interoute Communications Holdings S.A., there were delays in migrating Interoute’s legacy systems and processes into GTT’s client management database system; (2) Interoute had made a strategic priority shift to sell cloud services that was a higher percentage of Interoute’s sales in the two years leading up to the acquisition; (3) a material percentage of the Interoute sales representatives were not productive at selling GTT’s core cloud networking services; (4) GTT was unable to yield as many Interoute salespeople because Interoute had hired many sales people focused on cloud services and allowed underperforming sales representatives to remain at Interoute; and (5) as a result of the foregoing, Defendants’ public statements were materially false and/or misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in GTT: http://www.kleinstocklaw.com/pslra-1/gtt-communications-inc-loss-submission-form?id=3205&from=1

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 557588

NEW YORK, NY / ACCESSWIRE / August 27, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Venator Materials PLC (NYSE:VNTR)

Lawsuit on behalf of: investors who purchased (a) between August 2, 2017 and October 29, 2018, inclusive; (b) in or traceable to the Company’s initial public offering conducted on or around August 3, 2017; and (c) in or traceable to the Company’s secondary public offering conducted on or around December 4, 2017.
Lead Plaintiff Deadline : September 30, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/venator-materials-plc-loss-form?prid=3204&wire=1

According to the filed complaint, (a) the fire damage at the Pori facility was far more extensive than disclosed to investors, rendering the facility beyond repair; (b) the true cost of the Pori facility fire exceeded $1 billion, hundreds of millions of dollars beyond the limits of the Company’s insurance policy; (c) the Company was paying rebuilding premiums, and thereby incurring tens of millions of dollars in additional costs, in a futile attempt to expedite the rehabilitation process; (d) Venator had lost, essentially without prospect of rehabilitation, 80% of the production capacity of the Pori facility, and thus lost a substantial portion of one of its largest revenue producing assets; and (e) the Company’s reported annual Titanium Dioxide production capacity had been inflated by approximately 104,000 metric tons, or 15%.

Carbonite, Inc. (NASDAQ:CARB)

Lawsuit on behalf of: investors who purchased February 7, 2019 – July 25, 2019
Lead Plaintiff Deadline : September 30, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/carbonite-inc-loss-form?prid=3204&wire=1

According to the filed complaint, during the class period, Carbonite, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Carbonite’s Server Backup VM Edition was of poor quality and technologically flawed; (ii) Carbonite was receiving poor reviews and complaints from customers about the Server Backup VM Edition; (iii) the poor quality and technological flaws of the Server Backup VM Edition was acting as a “disruptive” factor throughout the Carbonite salesforce and keeping that sales organization from closing opportunistically on several larger deals during fiscal 2019; and (iv) as a result of the foregoing, Carbonite lacked any reasonable basis for issuing its positive projections and financial forecasts.

Abiomed, Inc. (NASDAQ:ABMD)

Lawsuit on behalf of: investors who purchased January 31, 2019 – July 31, 2019
Lead Plaintiff Deadline : October 7, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/abiomed-inc-loss-form?prid=3204&wire=1

According to the filed complaint, during the class period, Abiomed, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Abiomed’s revenue growth was in decline; (ii) the Company did not have a sufficient plan in place to stem its declining revenue growth; (iii) the Company was unlikely to restore its revenue growth over the next several fiscal quarters; (iv) consequently, Abiomed was reasonably likely to revise its full-year 2020 guidance in a way that would fall short of the Company’s prior projections and market expectations; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 557587

LOS ANGELES, CA / ACCESSWIRE / August 27, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fred’s Inc. (“Fred’s” or “the Company”) (NASDAQ:FRED) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between December 20, 2016 and June 28, 2017, inclusive (the ”Class Period”), are encouraged to contact the firm before August 27, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Fred’s entered into an agreement with Walgreens and Rite Aid Corp. to purchase 865 Rite Aid stores as a part of a merger plan between Walgreens and Rite Aid. The Company downplayed regulatory risk and disputed reports in the media that the merger was facing trouble. Fred’s also represented that it had inside information from the FTC that the Walgreens deal would close. Walgreens and Rite Aid announced on June 29, 2017, that they had terminated their merger plans, including the store sale to Fred’s. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Fred’s, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
Cell: 424-303-1964
info@schallfirm.com
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 557583

Actress-turned-attorney Kelly Hyman offers a closer look at a number of her career highlights to date.

DENVER, CO / ACCESSWIRE / August 27, 2019 / A successful attorney in the class action group at Franklin D. Azar & Associates in Denver, Colorado, lawyer Kelly Hyman is today primarily focused on consumer class action lawsuits. During her career to date, the attorney has represented hundreds of claimants in claims and individual actions, filed in both state and federal court. With some of her most high-profile cases involving tobacco litigation, transvaginal mesh lawsuits, and water contamination, Hyman looks back on a number of highlights from her successful and varied career.

“Prior to joining Franklin D. Azar & Associates, I represented clients in a class-action lawsuit concerning American Spirit,” reveals Hyman, “and served on its discovery committee.”

With extensive experience in mass tort litigation, Kelly Hyman has, to date, represented hundreds of claimants in claims and individual actions. “From cases filed in state courts to federal court, these include everything from water contamination to transvaginal mesh and bladder sling suits,” she explains.

Products featured in Kelly Hyman’s transvaginal mesh and bladder sling lawsuits include those supplied by Bard, Coloplast, Johnson & Johnson, Mentor, Boston Scientific, AMS, and ARIS. The highly successful attorney has also acted on multiple discovery committees and has performed common benefit services for a variety of mass tort projects.

Kelly Hyman is a member of the Florida Bar, the Washington D.C. Bar, the Colorado Bar, the Colorado Bar Association, as well as the Colorado chapter of the Federal Bar Association. Hyman is also a member of the American Association for Justice and routinely participates in the Women’s Caucus Lobby Day in Washington D.C.

Elsewhere, from 2017 to 2018, Kelly Hyman served as president of the Palm Beach Federal Bar Association. “I’m also a proud graduate,” she adds, “of the American Association for Justice’s leadership academy.”

Graduating from the University of California in Los Angeles and receiving her Juris Doctor degree cum laude from the University of Florida’s Levin College of Law, early on in her legal career Kelly Hyman clerked for the Honorable Robert Mark, United States Bankruptcy Judge for the Southern District of Florida. “I later went on to clerk,” she adds, “for the Honorable Brian Sandoval, now the former Governor of Nevada, when he was a United States District Court Judge.”

“While studying for my undergraduate degree,” Kelly Hyman continues, “I also served as a White House intern with the Office of Presidential Inquiries.”

Kelly Hyman has since received an AV Preeminent rating from Martindale-Hubbell and has lectured at numerous seminars on subjects ranging from mass tort litigation to mindfulness.

A native Floridian, Kelly Hyman was raised in New York City and southern California. Before turning her attention to law, Hyman enjoyed a successful career as an actress, appearing in various television shows, movies, Off-Broadway plays, commercials, and more.

The actress-turned-attorney regularly appears on the nation’s screens as a highly respected TV legal analyst.

CONTACT:
Caroline Hunter
Web Presence, LLC
+1 7865519491

SOURCE: Web Presence, LLC

ReleaseID: 557582